ALZ-101 / Alzinova 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ALZ-101 / Alzinova
NCT05328115: A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease

Recruiting
1
33
Europe
ALZ-101, Placebo
Alzinova AB, CRST Oy
Alzheimer Disease, Dementia Alzheimers, Dementia, Mild
01/25
01/25

Download Options